Blood | American Society of Hematology

Skip Nav Destination

Current Issue

Volume 144,

Issue 15,

October 10 2024

View This Issue

Issue Highlights

Using HSC-targeted nanoparticles to create a mouse model of α-thalassemia and gene therapy treatment
NGS-based stratification improves risk assessment in T-ALL
Preclinical insights into checkpoint inhibitor–induced AIHA
Optimizing drug combinations for T-PLL
Molecular taxonomy of myelodysplastic syndromes
Review: the intestinal microbiota and its influence on cellular therapy

Latest in Blood

Free Articles

Nonleukemic T/B mixed phenotype acute leukemia with PHF6 and NOTCH1 mutations

Oscar Silva; Allison Shaw

https://doi.org/10.1182/blood.2021012538

View All Free Articles

Plenary Papers

Critical role of tripartite fusion and LBD truncation in certain RARA - and all RARG -related atypical APL

Xiaosu Zhou; Xue Chen; Jiaqi Chen; Lijun Wen; Zhanglin Zhang; Ya-Zhen Qin; Panxiang Cao; Haizhou Xing; Yingchang Mi; Wei Wang; Guangsen Zhang; Ji Li; Huanling Wu; Zhifen Zhang; Jian Zhang; Zhan Su; Fang Wang; Yang Zhang; Xiaoli Ma; Jiancheng Fang; Ping Wu; Tong Wang; Gaowei Fan; Yang Zhao; David Jin; Xian Zhang; Xiujuan Ma; Qisheng Wu; Zhihua Zhang; Linya Wang; Futian Ma; Xia Xiao; Chengye Wu; Kai Sun; Ruijie Tang; Yun Zhang; Sanyun Wu; Ran Gao; Leping Zhang; Huyong Zheng; Yanli Zhao; Hong-Hu Zhu; Daopei Lu; Peihua Lu; Suning Chen; Hongxing Liu

https://doi.org/10.1182/blood.2024023883

View All Plenary Papers

First Edition

How I Treat Older Patients with Ph/BCR-ABL-Negative Acute Lymphoblastic Leukemia

Nicola Gökbuget; Björn Steffen

https://doi.org/10.1182/blood.2023023156

View All First Edition Articles

Clinical Trials and Observations

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Mathieu Simonin; Loïc Vasseur; Etienne Lengliné; Ludovic Lhermitte; Aurélie Cabannes-Hamy; Marie Balsat; Aline Schmidt; Marie-Emilie Dourthe; Aurore Touzart; Carlos Graux; Nathalie Grardel; Jean-Michel Cayuela; Isabelle Arnoux; Virginie Gandemer; Françoise Huguet; Stéphane Ducassou; Véronique Lhéritier; Yves Chalandon; Norbert Ifrah; Hervé Dombret; Elizabeth Macintyre; Arnaud Petit; Philippe Rousselot; Jérôme Lambert; André Baruchel; Nicolas Boissel; Vahid Asnafi

https://doi.org/10.1182/blood.2023023754

View All Clinical Trials and Observations

Advertisement intended for health care professionals

ASH Statement in Support of the Value of Scholarly Publishers

Acknowledgement of Reviewers

ASH Commitment to Diversity, Equity, and Inclusion in Health Care

Issue Highlights

Featured Content

Using NGS to refine risk stratification in T-ALL; a novel gene therapy approach in severe α-thalassemia; molecular taxonomy of MDS

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

Molecular taxonomy of myelodysplastic syndromes and its clinical implications

Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses

Mitigation of checkpoint inhibitor–induced autoimmune hemolytic anemia through modulation of purinergic signaling

ASH Publications

American Society of Hematology

Issue Highlights

Featured Content

Using NGS to refine risk stratification in T-ALL; a novel gene therapy approach in severe α-thalassemia; molecular taxonomy of MDS

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Use of HSC-targeted LNP to generate a mouse model of lethal α-thalassemia and treatment via lentiviral gene therapy

Molecular taxonomy of myelodysplastic syndromes and its clinical implications

Optimizing drug combinations for T-PLL: restoring DNA damage and P53-mediated apoptotic responses

Mitigation of checkpoint inhibitor–induced autoimmune hemolytic anemia through modulation of purinergic signaling

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only